Asthma (children under 5) - inhaler devices (TA10)
Fast, easy summary view of NICE guidance on 'asthma'
NICE has recommended that for children under the age of 5 years who have chronic stable asthma:
- both corticosteroids and bronchodilator therapy should routinely delivered by Pressurised Metered Dose Inhaler (pMDI) and spacer system, with a facemask where necessary.
- where this combination is not clinically effective for the child, and depending on the child's condition, nebulised therapy may be considered and in the case of children aged 3 to 5 years, a dry powder inhaler (DPI) may also be considered.
- the choice of which pMDI device and spacer to use should be determined by the specific needs of the child and how well it works for them. Once these factors have been taken into account the choice should be made on the basis of reducing costs.
Clinicians should review their current clinical practice for the management of chronic asthma in children under the age of 5 years against this guidance.
The appropriate selection of inhaler devices as described is only one aspect for the provision of a comprehensive approach to all aspects of managing asthma. In particular, parents/carers need education, support and guidance, on how to manage their child's condition. General practitioners, the practice nurse, the specialist asthma nurse, the health visitor and school nurse and other community health carers have an essential role in the provision of this service and advice on general management may result in additional improvements in clinical and cost effectiveness.
- TA10 Asthma (children under 5) - inhaler devices: guidance (web format)
- TA10 Asthma (children under 5) - inhaler devices: summary
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: asthma
- Asthma (children under 5) - inhaler devices: Static List Review Decision - March 2014
- Review decision
- Review proposal
- Review of NICE Technology Appraisal Guidance No 10: the use of inhaler systems (devices) in children under the age of 5 with chronic asthma
- HTA report for inhalers for under 5s with asthma
- Inhaler systems Appeal Decision - Children under 5 with Asthma
This page was last updated: 02 April 2014
- Web format
- Full Guidance (PDF)
- TA10 Arweiniad ar anadlyddion ar gyfer asthma plant: deall canllawiau NICE
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.